| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 08/04/2011 | US20110190360 Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| 08/04/2011 | US20110190283 Fab I Inhibitors |
| 08/04/2011 | US20110190280 Thiazole And Oxazole Kinase Inhibitors |
| 08/04/2011 | US20110190262 Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/04/2011 | US20110190236 Chemical compounds |
| 08/04/2011 | CA2787396A1 5-alkynyl pyrimidines and their use as kinase inhibitors |
| 08/04/2011 | CA2787246A1 Synthetic intermediate of oxazole compound and method for producing the same |
| 08/04/2011 | CA2780421A1 Gamma secretase modulaters |
| 08/03/2011 | EP2351757A1 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof |
| 08/03/2011 | EP2350097A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/03/2011 | EP2350090A2 Spiro-oxindole compounds and their use as therapeutic agents |
| 08/03/2011 | EP2350077A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| 08/03/2011 | EP2350053A2 Soluble mtor complexes and modulators thereof |
| 08/03/2011 | EP2349256A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 08/03/2011 | EP1949100B1 Method of tacrolimus extraction and quantification using aqueous detergents |
| 08/03/2011 | CN102143750A Macrocyclics pyrimidines as aurora kinase inhibitors |
| 08/03/2011 | CN102143746A CDK modulators |
| 08/03/2011 | CN102140120A Visible photochromic compound and synthesis method and application thereof |
| 08/03/2011 | CN102140102A Production method for directly extracting rifamycin S from fermentation filtrate |
| 08/03/2011 | CN101253180B 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands |
| 08/02/2011 | US7989640 Sulfonylpyrrolidine modulators of androgen receptor function and method |
| 08/02/2011 | US7989448 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 08/02/2011 | US7989444 Compounds having affinity for dopamine D3 receptor and uses thereof |
| 08/02/2011 | US7989442 (cis)-8-fluorodibenzo[b,f]pyrido[1,2-d]oxazepine-1-amine derivatives; contraception, hormone replacement therapy (HRT) or gynaecological disorders, adjuvant therapy in cancer |
| 08/02/2011 | CA2474043C Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 07/28/2011 | WO2011090911A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 07/28/2011 | US20110184167 Process for the preparation of temsirolimus and its intermediates |
| 07/28/2011 | US20110182856 Inhibitors of serine proteases |
| 07/28/2011 | CA2788363A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 07/27/2011 | EP2348024A2 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 07/27/2011 | EP2346871A1 Alpha helix mimetics in the treatment of cancer |
| 07/27/2011 | EP2346823A1 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds |
| 07/27/2011 | CN102137844A Compounds and compositions as modulators of GPR119 activity |
| 07/27/2011 | CN102134245A Tetralin isoquinoline compounds as well as preparation methods and applications thereof |
| 07/27/2011 | CN101155816B (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as HIV viral replication inhibitors |
| 07/26/2011 | CA2487976C Calcitonin gene related peptide receptor antagonists |
| 07/21/2011 | WO2011087155A1 Polylactic acid composition |
| 07/21/2011 | WO2011086081A1 2,5-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | WO2011086080A1 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086079A1 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086078A1 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086077A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086075A1 2,5,7-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | WO2011085643A1 Fused pyridine derivatives |
| 07/21/2011 | US20110178308 Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof |
| 07/21/2011 | US20110178199 Method for producing organic compound and organic compound obtained by the method |
| 07/21/2011 | US20110178117 Oxazolobenzimidazole derivatives |
| 07/21/2011 | US20110178075 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178055 Dual nk1/nk3 receptor antagonists |
| 07/21/2011 | US20110177152 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 07/21/2011 | CA2804128A1 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2799474A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2792134A1 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2791445A1 2,5,7-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | CA2784565A1 2,5-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | CA2784560A1 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/20/2011 | CN102131816A Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
| 07/20/2011 | CN102131790A Novel phenolic and catecholic amines and prodrugs thereof |
| 07/20/2011 | CN102127092A Preparation of Everolimus |
| 07/20/2011 | CN102127087A 喹唑啉衍生物 Quinazoline derivatives |
| 07/20/2011 | CN102127072A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127071A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127070A Pyridine cyclo-derivative |
| 07/20/2011 | CN101659669B Method for preparing levofloxacin |
| 07/20/2011 | CN101481381B Method for preparing ciprofloxacin by piperazine reaction |
| 07/20/2011 | CN101312965B Morpholine type cinnamide compound |
| 07/19/2011 | US7982040 Thienopyridinone compounds and methods of treatment |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981881 Fused heterocyclic compounds and use thereof |
| 07/19/2011 | US7981879 HIV integrase inhibitors |
| 07/19/2011 | CA2397354C O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/14/2011 | US20110173726 Pyrazole Compounds for Controlling Invertebrate Pests |
| 07/14/2011 | US20110172420 Sulfonamide derivatives of polycyclic dyes used for analytical applications |
| 07/14/2011 | US20110172415 Nitrogen-containing heterocycle derivatives substituted with cyclic group |
| 07/14/2011 | US20110172413 Purification method of lactone compounds containing unsaturated alkyl group by extraction with silver ion solution |
| 07/14/2011 | US20110172221 Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereof |
| 07/14/2011 | US20110172219 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 07/14/2011 | US20110172218 Cgrp antagonists |
| 07/14/2011 | US20110172217 Ring-fused morpholine derivative having pi3k-inhibiting activity |
| 07/14/2011 | US20110172206 Compositions and methods for treatment of neurodegenerative disease |
| 07/14/2011 | US20110172191 Thieno-pyridine derivatives as mek inhibitors |
| 07/14/2011 | US20110171172 Compounds for inhibiting ksp kinesin activity |
| 07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
| 07/13/2011 | EP2342335A1 Novel gene cluster |
| 07/13/2011 | EP2342179A1 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases |
| 07/13/2011 | EP2341777A1 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions |
| 07/12/2011 | US7977491 Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound |
| 07/12/2011 | US7977353 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 07/12/2011 | US7977349 Substituted quinolones III |
| 07/12/2011 | US7977327 Substituted pyrrolidine derivative |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2417858C Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 07/07/2011 | WO2011081205A1 1,3,4-oxadiazole-2-carboxamide compound |
| 07/07/2011 | WO2011080691A1 Method for the production of amorphous rifaximin |
| 07/07/2011 | US20110166297 MOLECULARLY IMPRINTED SMART POLYMERS (MISPs) |
| 07/07/2011 | US20110166131 Substituted pyrrolidine derivative |
| 07/07/2011 | US20110166124 Tricyclic spirocycle derivatives and methods of use |
| 07/07/2011 | US20110166123 Novel compositions and methods of use |
| 07/07/2011 | US20110166110 Fused Ring Azadecalin Glucocorticoid Receptor Modulators |